PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers

被引：2
|
作者：
Stebbing, Justin [1 ]
Ellis, Paul [2 ,3 ]
Tutt, Andrew [4 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Oncol & Surg, London W12 0NN, England
[2] Guys & St Thomas NHS Trust, Dept Oncol, London, England
[3] Kings Coll Hosp, London, England
[4] Guys Hosp, Breakthrough Breast Canc Res Unit, Kings Hlth Partners AHSC, London SE1 9RT, England
来源：
FUTURE ONCOLOGY | 2010年 / 6卷 / 04期
关键词：
breast cancer; BRCA; PARP inhibitor; triple negative; POLY(ADP-RIBOSE) POLYMERASE; RESISTANCE; DNA; REPAIR; MUTATIONS; TUMORS; BRCA1;
D O I：
10.2217/FON.10.27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：485 / 486
页数：2
相关论文
共 50 条
  • [21] PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
    Ibrahim, Yasir H.
    Garcia-Garcia, Celina
    Serra, Violeta
    He, Lei
    Torres-Lockhart, Kristine
    Prat, Aleix
    Anton, Pilar
    Cozar, Patricia
    Guzman, Marta
    Grueso, Judit
    Rodriguez, Olga
    Teresa Calvo, Maria
    Aura, Claudia
    Diez, Orland
    Rubio, Isabel T.
    Perez, Jose
    Rodon, Jordi
    Cortes, Javier
    Ellisen, Leif W.
    Scaltriti, Maurizio
    Baselga, Jose
    CANCER DISCOVERY, 2012, 2 (11) : 1036 - 1047
  • [22] p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours
    Crook, T
    Brooks, LA
    Crossland, S
    Osin, P
    Barker, KT
    Waller, J
    Philp, E
    Smith, PD
    Yulug, I
    Peto, J
    Parker, G
    Allday, MJ
    Crompton, MR
    Gusterson, BA
    ONCOGENE, 1998, 17 (13) : 1681 - 1689
  • [23] p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours
    Tim Crook
    Louise A Brooks
    Susan Crossland
    P Osin
    Karen T Barker
    Joanne Waller
    Elizabeth Philp
    Paul D Smith
    Isik Yulug
    Julian Peto
    Gillian Parker
    Martin J Allday
    Mark R Crompton
    Barry A Gusterson
    Oncogene, 1998, 17 : 1681 - 1689
  • [24] 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
    Bouwman, Peter
    Aly, Amal
    Escandell, Jose M.
    Pieterse, Mark
    Bartkova, Jirina
    van der Gulden, Hanneke
    Hiddingh, Sanne
    Thanasoula, Maria
    Kulkarni, Atul
    Yang, Qifeng
    Haffty, Bruce G.
    Tommiska, Johanna
    Blomqvist, Carl
    Drapkin, Ronny
    Adams, David J.
    Nevanlinna, Heli
    Bartek, Jiri
    Tarsounas, Madalena
    Ganesan, Shridar
    Jonkers, Jos
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2010, 17 (06) : 688 - U56
  • [25] PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies
    Lee, J-m.
    Ledermann, J. A.
    Kohn, E. C.
    ANNALS OF ONCOLOGY, 2014, 25 (01) : 32 - 40
  • [26] Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer
    Carey, Jason. P. W.
    Karakas, Cansu
    Bui, Tuyen
    Chen, Xian
    Vijayaraghavan, Smruthi
    Zhao, Yang
    Wang, Jing
    Mikule, Keith
    Litton, Jennifer K.
    Hunt, Kelly K.
    Keyomarsi, Khandan
    CANCER RESEARCH, 2018, 78 (03) : 742 - 757
  • [27] Clinical and Pathologic Differences Between BRCA1-, BRCA2-, and Non-BRCA-Associated Breast Cancers in a Multiracial Developing Country
    Cheng-Har Yip
    N. A. Taib
    W. Y. Choo
    S. Rampal
    M. K. Thong
    S. H. Teo
    World Journal of Surgery, 2009, 33 : 2077 - 2081
  • [28] Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: talazoparib
    McCann, Kelly E.
    FUTURE ONCOLOGY, 2019, 15 (15) : 1707 - 1715
  • [29] Breast-conserving therapy in women with BRCA1/BRCA2-associated breast cancer
    Khan A.
    Haffty B.G.
    Current Breast Cancer Reports, 2010, 2 (2) : 90 - 95
  • [30] The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer
    Luo, Jiayan
    Jin, Juan
    Yang, Fang
    Sun, Zijia
    Zhang, Wenwen
    Shi, Yaqin
    Xu, Jing
    Guan, Xiaoxiang
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2016, 12 (12): : 1500 - 1510
12345